Aptevo Therapeutics, Inc. (APVO)
1.87
-0.01
(-0.53%)
USD |
NASDAQ |
Sep 09, 16:00
1.80
-0.07
(-3.74%)
After-Hours: 17:07
Aptevo Therapeutics Total Liabilities (Quarterly) : 8.478M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.478M |
| March 31, 2026 | 8.29M |
| December 31, 2025 | 10.61M |
| September 30, 2025 | 9.604M |
| June 30, 2025 | 9.10M |
| March 31, 2025 | 9.815M |
| December 31, 2024 | 10.84M |
| September 30, 2024 | 10.73M |
| June 30, 2024 | 10.46M |
| March 31, 2024 | 11.53M |
| December 31, 2023 | 12.62M |
| September 30, 2023 | 12.41M |
| June 30, 2023 | 12.66M |
| March 31, 2023 | 11.71M |
| December 31, 2022 | 16.24M |
| September 30, 2022 | 15.93M |
| June 30, 2022 | 15.75M |
| March 31, 2022 | 51.07M |
| December 31, 2021 | 55.38M |
| September 30, 2021 | 56.71M |
| June 30, 2021 | 57.59M |
| Date | Value |
|---|---|
| March 31, 2021 | 58.25M |
| December 31, 2020 | 36.95M |
| September 30, 2020 | 35.22M |
| June 30, 2020 | 9.859M |
| March 31, 2020 | 10.09M |
| December 31, 2019 | 41.57M |
| September 30, 2019 | 40.81M |
| June 30, 2019 | 39.93M |
| March 31, 2019 | 41.71M |
| December 31, 2018 | 37.09M |
| September 30, 2018 | 34.93M |
| June 30, 2018 | 33.97M |
| March 31, 2018 | 31.85M |
| December 31, 2017 | 34.97M |
| September 30, 2017 | 40.71M |
| June 30, 2017 | 35.47M |
| March 31, 2017 | 36.31M |
| December 31, 2016 | 41.29M |
| September 30, 2016 | 36.87M |
| June 30, 2016 | 20.96M |
| March 31, 2016 | 22.74M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.52M |
| Shareholders Equity (Quarterly) | 6.041M |
| Debt to Equity Ratio | 0.6967 |
| Current Ratio | 2.081 |
| Net Debt Paydown Yield | 0.68% |